Repligen | RGEN - Trade Debtors

Stock Price
140.61
Daily Change
0.95 0.68%
Monthly
-16.82%
Yearly
-9.89%
Q1 Forecast
144.77

Repligen reported $148.97M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Agilent USD 1.49B 105M Sep/2025
Align Technology USD 1.1B 2.38M Dec/2025
Bio Techne USD 184.61M 717K Dec/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Bruker USD 550.9M 28.3M Sep/2025
Charles River Laboratories USD 1.48B 715.2M Sep/2025
Danaher USD 3.91B 762M Dec/2025
Dentsply International USD 654M 8M Sep/2025
Exact Sciences USD 306.05M 47.28M Sep/2025
General Electric Aerospace USD 15.28B 1.5B Dec/2025
Henry Schein USD 1.74B 98M Sep/2025
Illumina USD 854M 125M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Myriad Genetics USD 118M 19M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Repligen USD 148.97M 7.98M Sep/2025
Revvity USD 680.26M 19.12M Sep/2025
Standard Biotools USD 13.54M 1.07M Sep/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
Waters USD 748.52M 18.44M Sep/2025
West Pharmaceutical Services USD 625M 42.6M Sep/2025